The inhibitor of AKT signaling reduced activation of AKT signaling-related proteins such as mTOR, PRAS40, and ribosomal protein S6 kinase (S6K1) in HCC [39]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.